MTE24.02 Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.080
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Imaging Follow-Up After Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

MS20.02 the Future of Stereotactic Ablative Radiotherapy (SABR)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Retrospective Analysis of Intrafraction Motion in Lung Stereotactic Ablative Body Radiotherapy (SABR) Patients at the Fraser Valley Centre

Journal of Medical Imaging and Radiation Sciences
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2018English

P2.16-15 Toxicities and Survival After Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.16-15 Kinetic Energy Distribution for Gated Technique at Lung Ablative Body Radiotherapy (SABR)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Population-Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to 5 Oligometastases: SABR-5

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

P3.08-17 Paediatric Motion Management Solutions for Particle Therapy Based Thoracic Stereotactic Ablative Body Radiotherapy (SABR)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.16-26 Safety of SABR (Stereotactic Ablative Body Radiotherapy) for Central Non-Small Cell Lung Cancers (cNSCLC) With 50 Gray in 5 Fractions (50Gy/5f)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Lung Stereotactic Body Radiotherapy After Past Ablative Therapy: A Single Institution Case Series

Lung Cancer Management
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy